Evidence map›Paper›PMID 26459891›Full record

ArticleAntimicrobial agents and chemotherapy2015

A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.

Chui-Yoke Chin, Kelsey A Gregg, Brooke A Napier, Robert K Ernst, David S Weiss

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 80 citations in OpenAlex.

  1. Membrane-Focused Strategies AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  2. Resistance, heteroresistance, and fitness costs drive colistin treatment failure duringProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  5. Article
  6. PmrA Mutations in Drug-ResistantMicroorganisms · 2025
    Article
  7. Review
  8. Construction and Characterization of an lpxM-DeficientInfection and drug resistance · 2025
    Article
  9. Review
  10. Review
  11. PmrAB, the two-component system ofJournal of bacteriology · 2024
    Article
  12. Treatment Strategies of Colistin ResistanceAntibiotics (Basel, Switzerland) · 2024
    Review
  13. Article
  14. Frontiers in microbiology · 2024
    Review
  15. Article
  16. Antibiotics (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chui-Yoke ChinEmory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, USA Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia, USA Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Kelsey A GreggDepartment of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
Brooke A NapierEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia, USA Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Robert K ErnstDepartment of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
David S WeissEmory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, USA Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia, USA Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA david.weiss@emory.edu.
Emory University · USUniversity of Maryland, Baltimore · US

Funding

Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
ArmR: a novel drug target and mediator of antibiotic resistanceR33AI098800 · NIAID · EMORY UNIVERSITY · PI WEISS, DAVID S · 2014 to 2016
$1.6M
ArmR: a novel drug target and mediator of antibiotic resistanceR21AI098800 · NIAID · EMORY UNIVERSITY · PI WEISS, DAVID S · 2012 to 2013
$473k
NIAID NIH HHS AI098800NIAID NIH HHS R21 AI098800NIAID NIH HHS R33 AI098800NIAID NIH HHS T32 AI095190
6 · The paper itself

Abstract

Emerging resistance to "last-resort" polymyxin antibiotics in Gram-negative bacteria is a significant threat to public health. We identified the Acinetobacter baumannii NaxD deacetylase as a critical mediator of lipid A modification resulting in polymyxin resistance and demonstrated that naxD is regulated by the sensor kinase PmrB. This represents the first description of a specific PmrB-regulated gene contributing to polymyxin resistance in A. baumannii and highlights NaxD as a putative drug target to reverse polymyxin resistance.

Indexed as

Gene Expression Regulation, BacterialAcinetobacter baumanniiAcinetobacter InfectionsAmidohydrolasesAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialHumansLipid AMicrobial Sensitivity TestsMolecular StructurePolymyxin BTranscription Factorsacetylgalactosamine deacetylaseAmidohydrolasesAnti-Bacterial AgentsBacterial ProteinsLipid APmrB protein, bacteriaPolymyxin BTranscription Factors

Identifiers

PMID26459891
PMCPMC4649237
OpenAlexW2412841056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.